Amed Co., Ltd.
TTPEX:757511.00
TWD
+0.30
(+2.80%)
Amed Co., Ltd.
TPEX:7575
(Taipei Exchange)
Recent
price
11.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
TWD
•
in mil. unless spec.Working Capital
TWD
•
in mil. unless spec.Growth Rates
TWD
•
in mil. unless spec.Semi-annual Revenue
TWD
•
in mil. unless spec.Semi-annual Earnings Per Share
TWD
•
in mil. unless spec.Semi-annual Dividends Per Share
TWD
•
in mil. unless spec.- Similar Companies
- Business
- Amed Co., Ltd. Amed Co., Ltd. engages in the research, development, manufacture, and trading of medical equipment primarily focused on wound care and pain management solutions in Taiwan. The company offers wound care dressing products under the HERADERM brand name; negative pressure wound therapy systems providing 24-hour oxygen supply to wounds under the Genadyne brand name; wound treatment systems under the Natrox brand name; 7-day long-acting pain reliever injections under the Naldebain brand name; pressure injectable implantable port kits under the POLYSITE brand; and universal linear cutting staplers under the easyEndo brand name. Founded in 2008 and headquartered at No.14-1, Wuquan 7th Road, Wugu District, New Taipei City, Taiwan, Amed Co., Ltd. operates within the healthcare sector, specifically medical instruments and supplies, serving domestic markets including medical centers and regional hospitals with approximately 165 employees. The company listed on the Taipei Exchange in August 2020 under ticker 7575 with an ISIN of TW0007575B17 and maintains a contributed capital of NT$300 million. Recent developments include expansions in product applications, such as new HERADERM dressing products broadening scope as of November 2021, alongside ongoing innovations in orthopedic surgery care and specialized wound management presentations.